Kim HA - Search Results

1

Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.

Heon Seo K, Ko HM, Kim HA, Choi JH, Jun Park S, Kim KJ, Lee HK, Im SY. Heon Seo K, et al. Among authors: kim kj, kim ha. Cancer Res. 2006 May 1;66(9):4681-6. doi: 10.1158/0008-5472.CAN-05-3186. Cancer Res. 2006. PMID: 16651419

2

Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis.

Ko HM, Park YM, Jung B, Kim HA, Choi JH, Park SJ, Lee HK, Im SY. Ko HM, et al. Among authors: kim ha. FEBS Lett. 2005 Apr 25;579(11):2369-75. doi: 10.1016/j.febslet.2005.03.035. FEBS Lett. 2005. PMID: 15848174 Free article.

3

Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity.

Ko HM, Jung HH, Seo KH, Kang YR, Kim HA, Park SJ, Lee HK, Im SY. Ko HM, et al. Among authors: kim ha. FEBS Lett. 2006 May 29;580(13):3006-12. doi: 10.1016/j.febslet.2006.04.042. Epub 2006 Apr 25. FEBS Lett. 2006. PMID: 16684540 Free article.

4

Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.

Ko HM, Kang JH, Jung B, Kim HA, Park SJ, Kim KJ, Kang YR, Lee HK, Im SY. Ko HM, et al. Among authors: kim kj, kim ha. Int J Cancer. 2007 Mar 15;120(6):1277-83. doi: 10.1002/ijc.22450. Int J Cancer. 2007. PMID: 17187368

5

Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.

Kim HA, Kim SH, Ko HM, Choi JH, Kim KJ, Oh SH, Cho KO, Choi IW, Im SY. Kim HA, et al. Among authors: kim kj, kim sh. Immunology. 2008 Jul;124(3):428-35. doi: 10.1111/j.1365-2567.2007.02795.x. Epub 2008 Apr 4. Immunology. 2008. PMID: 18397269 Free PMC article.

6

CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.

Kim HA, Ko HM, Ju HW, Kim KJ, Roh SG, Lee HK, Im SY. Kim HA, et al. Among authors: kim kj. Cancer Lett. 2009 Feb 8;274(1):160-4. doi: 10.1016/j.canlet.2008.09.014. Epub 2008 Oct 25. Cancer Lett. 2009. PMID: 18952369

7

Mechanisms of platelet-activating factor-induced enhancement of VEGF expression.

Kim HA, Seo KH, Kang YR, Ko HM, Kim KJ, Back HK, Lee HK, Im SY. Kim HA, et al. Among authors: kim kj. Cell Physiol Biochem. 2011;27(1):55-62. doi: 10.1159/000325205. Epub 2011 Feb 11. Cell Physiol Biochem. 2011. PMID: 21325822

8

Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis.

Kim HA, Kim KJ, Yoon SY, Lee HK, Im SY. Kim HA, et al. Among authors: kim kj. Eur J Cancer. 2012 Jul;48(11):1730-8. doi: 10.1016/j.ejca.2011.07.013. Epub 2011 Aug 31. Eur J Cancer. 2012. PMID: 21889331

9

PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis.

Kim HA, Kim KJ, Seo KH, Lee HK, Im SY. Kim HA, et al. Among authors: kim kj. FEBS Lett. 2012 Dec 14;586(24):4296-302. doi: 10.1016/j.febslet.2012.10.034. Epub 2012 Nov 5. FEBS Lett. 2012. PMID: 23137704 Free article.

10

Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation.

Kim KJ, Cho KD, Jang KY, Kim HA, Kim HK, Lee HK, Im SY. Kim KJ, et al. Among authors: kim hk, kim ha. Immunology. 2014 Sep;143(1):21-32. doi: 10.1111/imm.12283. Immunology. 2014. PMID: 24628121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,022 results

Search Page

Filters